These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Loss of p16 expression and copy number changes of CDKN2A in a spectrum of spitzoid melanocytic lesions. Harms PW, Hocker TL, Zhao L, Chan MP, Andea AA, Wang M, Harms KL, Wang ML, Carskadon S, Palanisamy N, Fullen DR. Hum Pathol; 2016 Dec; 58():152-160. PubMed ID: 27569296 [Abstract] [Full Text] [Related]
5. Differentiation between Spitz nevi and malignant melanomas by interphase fluorescence in situ hybridization. Wettengel GV, Draeger J, Kiesewetter F, Schell H, Neubauer S, Gebhart E. Int J Oncol; 1999 Jun; 14(6):1177-83. PubMed ID: 10339676 [Abstract] [Full Text] [Related]
7. p16 expression: a marker of differentiation between childhood malignant melanomas and Spitz nevi. Al Dhaybi R, Agoumi M, Gagné I, McCuaig C, Powell J, Kokta V. J Am Acad Dermatol; 2011 Aug; 65(2):357-363. PubMed ID: 21550132 [Abstract] [Full Text] [Related]
11. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions. Nasr MR, El-Zammar O. Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113 [Abstract] [Full Text] [Related]
13. Fatty acid synthase expression in cutaneous melanocytic neoplasms. Kapur P, Rakheja D, Roy LC, Hoang MP. Mod Pathol; 2005 Aug; 18(8):1107-12. PubMed ID: 15920554 [Abstract] [Full Text] [Related]
14. Analysis of mutations in B-RAF, N-RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma. van Dijk MC, Bernsen MR, Ruiter DJ. Am J Surg Pathol; 2005 Sep; 29(9):1145-51. PubMed ID: 16096402 [Abstract] [Full Text] [Related]
15. BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations. Piris A, Mihm MC, Hoang MP. Hum Pathol; 2015 Feb; 46(2):239-45. PubMed ID: 25479927 [Abstract] [Full Text] [Related]
16. Genomic analysis of a case of agminated Spitz nevi and congenital-pattern nevi arising in extensive nevus spilus. Porubsky C, Teer JK, Zhang Y, Deschaine M, Sondak VK, Messina JL. J Cutan Pathol; 2018 Feb; 45(2):180-183. PubMed ID: 29210482 [Abstract] [Full Text] [Related]
17. Quantitative in situ evaluation of telomeres in fluorescence in situ hybridization-processed sections of cutaneous melanocytic lesions and correlation with telomerase activity. Miracco C, Margherita De Santi M, Schürfeld K, Santopietro R, Lalinga AV, Fimiani M, Biagioli M, Brogi M, De Felice C, Luzi P, Andreassi L. Br J Dermatol; 2002 Mar; 146(3):399-408. PubMed ID: 11952539 [Abstract] [Full Text] [Related]
19. A comparative immunohistochemical study of MART-1 expression in Spitz nevi, ordinary melanocytic nevi, and malignant melanomas. Bergman R, Azzam H, Sprecher E, Manov L, Munichor M, Friedman-Birnbaum R, Ben-Itzhak O. J Am Acad Dermatol; 2000 Mar; 42(3):496-500. PubMed ID: 10688724 [Abstract] [Full Text] [Related]
20. Cyclin D1 overexpression in Spitz nevi: an immunohistochemical study. Nagasaka T, Lai R, Medeiros LJ, Brynes RK, McCourty A, Harada T, Saddik M. Am J Dermatopathol; 1999 Apr; 21(2):115-20. PubMed ID: 10218669 [Abstract] [Full Text] [Related] Page: [Next] [New Search]